NF1 deficiency drives metabolic reprogramming in ER+ breast cancer
Objective: NF1 is a tumor suppressor gene and its protein product, neurofibromin, is a negative regulator of the RAS pathway. NF1 is one of the top driver mutations in sporadic breast cancer such that 27 % of breast cancers exhibit damaging NF1 alterations. NF1 loss-of-function is a frequent event i...
Saved in:
Main Authors: | Rachel (Rae) (Author), Elizabeth A. Tovar (Author), Luke N. Redlon (Author), Curt J. Essenburg (Author), Patrick S. Dischinger (Author), Abigail E. Ellis (Author), Ian Beddows (Author), Ryan D. Sheldon (Author), Evan C. Lien (Author), Carrie R. Graveel (Author), Matthew R. Steensma (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the decisive factors driving fate bifurcations in somatic cell reprogramming
by: Chunshen Long, et al.
Published: (2023) -
NFκB and AP-1 Drive Human Myometrial IL8 Expression
by: Shirin Khanjani, et al.
Published: (2012) -
Aqueous Extract of Cimicifuga dahurica Reprogramming Macrophage Polarization by Activating TLR4-NF-κB Signaling Pathway
by: Qian S, et al.
Published: (2022) -
Metabolic reprogramming in osteosarcoma
by: Yulu Shi, et al.
Published: (2023) -
Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis
by: Yuan Gui, et al.
Published: (2023)